Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G.

J Natl Cancer Inst. 1999 Jun 2;91(11):961-6.

PMID:
10359549
2.

Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.

3.

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.

Cancer Res. 2002 Feb 15;62(4):1045-9.

4.

Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.

Santarosa M, Bidoli E, Gallo A, Steffan A, Boiocchi M, Viel A.

Oncol Rep. 2002 May-Jun;9(3):639-44.

PMID:
11956643
5.

Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.

Wu MH, Chou YC, Yu CP, Yang T, You SL, Chen CJ, Sun CA.

Eur J Cancer Prev. 2008 Aug;17(4):317-22. doi: 10.1097/CEJ.0b013e3282f75e7f.

PMID:
18562955
6.

Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.

Southey MC, Batten LE, McCredie MR, Giles GG, Dite G, Hopper JL, Venter DJ.

J Natl Cancer Inst. 1998 Apr 1;90(7):532-6.

PMID:
9539249
7.

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.

Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ.

Hepatology. 2002 Jul;36(1):156-63.

PMID:
12085360
8.

Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.

Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, Halabi S, Calingaert B, Gusberg A, Marks JR, Berchuck A.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):473-80.

9.

Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.

Liede A, Zhang W, De Leon Matsuda ML, Tan A, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):848-52.

10.

Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):337-41.

11.

A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.

Beilin J, Harewood L, Frydenberg M, Mameghan H, Martyres RF, Farish SJ, Yue C, Deam DR, Byron KA, Zajac JD.

Cancer. 2001 Aug 15;92(4):941-9.

PMID:
11550169
12.

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA.

J Natl Cancer Inst. 1997 Jan 15;89(2):166-70.

PMID:
8998186
13.

Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.

Mehdipour P, Pirouzpanah S, Kheirollahi M, Atri M.

Breast J. 2011 Jan-Feb;17(1):39-46. doi: 10.1111/j.1524-4741.2010.01031.x. Epub 2010 Dec 16.

PMID:
21159020
14.

Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.

Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA, Ferrell RE.

Clin Cancer Res. 2001 Oct;7(10):3092-6.

15.

Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis.

Hao Y, Montiel R, Li B, Huang E, Zeng L, Huang Y.

Breast Cancer Res Treat. 2010 Dec;124(3):815-20. doi: 10.1007/s10549-010-0907-y. Epub 2010 Apr 30.

PMID:
20431938
16.

Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.

Gsur A, Preyer M, Haidinger G, Zidek T, Madersbacher S, Schatzl G, Marberger M, Vutuc C, Micksche M.

Carcinogenesis. 2002 Oct;23(10):1647-51.

PMID:
12376473
17.

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C.

Cancer Res. 2000 Sep 15;60(18):5111-6.

18.
19.

A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.

Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF.

Calcif Tissue Int. 2003 Sep;73(3):237-43.

PMID:
14667136
20.

Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.

Giguère Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J, Rousseau F.

Cancer Res. 2001 Aug 1;61(15):5869-74.

Supplemental Content

Support Center